Virological and Serological Characterisation of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination Between December 2020 and March 2021

Virological and Serological Characterisation of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination Between December 2020 and March 2021

BackgroundVaccines for coronavirus disease 2019 (COVID-19) are proving to be very effective in preventing severe illness; however, although rare, post-vaccine infections have been reported. The present study focuses on virological and serological features of 94 infections that occurred in Lazio Regi...

Full description

Bibliographic Details
Main Authors: Francesca Colavita, Silvia Meschi, Cesare Ernesto Maria Gruber, Martina Rueca, Francesco Vairo, Giulia Matusali, Daniele Lapa, Emanuela Giombini, Gabriella De Carli, Martina Spaziante, Francesco Messina, Giulia Bonfiglio, Fabrizio Carletti, Eleonora Lalle, Lavinia Fabeni, Giulia Berno, Vincenzo Puro, Barbara Bartolini, Antonino Di Caro, Giuseppe Ippolito, Maria Rosaria Capobianchi, Concetta Castilletti
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Medicine
Subjects:
COVID-19
SARS-CoV-2
viral variants
neutralising antibodies
vaccine
breakthrough infection
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.815870/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.815870/full

Similar Items